Jack Resneck Jr., MD
Professor
Dermatology
School of Medicine

Dr. Resneck became president of the American Medical Association in June 2022. He is a passionate advocate for physicians and patients, a prominent spokesperson for innovation, and a champion for a more equitable health care system. Whether testifying before Congress about removing dysfunction from health care, caring for his patients at UCSF, or advocating for physician values in emerging technology, Dr. Resneck channels his leadership to improve the lives of patients and the working environment for America’s physicians to help build stronger, healthier communities.

Dr. Resneck was elected to the American Medical Association Board of Trustees in 2014 and served as its chair from 2018 to 2019. He is a former member of the board of the American Academy of Dermatology and the former president of the California Society for Dermatology and Dermatologic Surgery. Currently, he is a member of the editorial board of the Journal of the American Academy of Dermatology and serves on the board of directors for the National Quality Forum. He is active in health services research, and his studies on patient access to care, health care delivery, telemedicine and public health have been published in prominent journals and attracted national media attention. He is a sought-after speaker and has given dozens of invited lectureships around the country.

Dr. Resneck’s leadership is collaborative, inclusive, focused and infused with purpose. This is evident whether he is engaging the AMA’s Litigation Center to protect physicians’ free speech and fight societal discrimination against marginalized patients—or advocating on Capitol Hill for fair Medicare payment systems, improved patient access to care, lower prescription drug prices, and reduced dysfunction and burdens in health care.

Raised in Louisiana, Dr. Resneck received his BA in public policy from Brown University and his MD from UCSF—where he also completed his internship in internal medicine, residency in dermatology and fellowship in health policy.

• Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
  JAMA network open 2020 Yang EJ, Galan E, Thombley R, Lin A, Seo J, Tseng CW, Resneck JS, Bach PB, Dudley RA
• Refocusing Medication Prior Authorization on Its Intended Purpose.
  JAMA 2020 Resneck JS
• Physicians Respond to Accurate, Actionable Data on Their Performance.
  JAMA dermatology 2019 Resneck JS, VanBeek M
• Dermatology Practice Consolidation Fueled by Private Equity Investment: Potential Consequences for the Specialty and Patients.
  JAMA dermatology 2018 Resneck JS
• A risk adjustment approach to estimating the burden of skin disease in the United States.
  Journal of the American Academy of Dermatology 2017 Lim HW, Collins SAB, Resneck JS, Bolognia J, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Begolka WS, Moyano JV
• Contribution of health care factors to the burden of skin disease in the United States.
  Journal of the American Academy of Dermatology 2017 Lim HW, Collins SAB, Resneck JS, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV
• The burden of skin disease in the United States.
  Journal of the American Academy of Dermatology 2017 Lim HW, Collins SAB, Resneck JS, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV
• Transparency Associated With Interactions Between Industry and Physicians: Deficits in Accuracy and Consistency of Public Data Releases.
  JAMA dermatology 2016 Resneck JS
• Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps Treating Skin Disease.
  JAMA dermatology 2016 Resneck JS, Abrouk M, Steuer M, Tam A, Yen A, Lee I, Kovarik CL, Edison KE
• Online Advertising for Cancer Prevention: Google Ads and Tanning Beds.
  JAMA dermatology 2016 Cidre Serrano W, Chren MM, Resneck JS, Aji NN, Pagoto S, Linos E
• Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer--Reply.
  JAMA dermatology 2015 Linos E, VanBeek M, Resneck JS
• A Sudden and Concerning Increase in the Use of Electronic Brachytherapy for Skin Cancer.
  JAMA dermatology 2015 Linos E, VanBeek M, Resneck JS
• What dermatology still needs to create meaningful patient outcome measurements.
  JAMA dermatology 2015 Resneck JS, VanBeek M
• The accuracy of dermatology network physician directories posted by Medicare Advantage health plans in an era of narrow networks.
  JAMA dermatology 2014 Resneck JS, Quiggle A, Liu M, Brewster DW
• Twitter: an opportunity for public health campaigns.
  Lancet (London, England) 2014 Wehner MR, Chren MM, Shive ML, Resneck JS, Pagoto S, Seidenberg AB, Linos E
• Compliance by California tanning facilities with the nation's first statewide ban on use before the age of 18 years.
  Journal of the American Academy of Dermatology 2013 Grewal SK, Haas AF, Pletcher MJ, Resneck JS
• Research agenda consensus conference.
  Journal of the American Academy of Dermatology 2013 Lim HW, Resneck JS, Fischoff R
• Dermatology workforce policy then and now: reflections on Dr Peyton Weary's 1979 manuscript.
  Journal of the American Academy of Dermatology 2013 Resneck JS
• An analysis of dermatologist migration patterns after residency training.
  Archives of dermatology 2011 Resneck JS, Kostecki J
• An analysis of health system reform for dermatologists: elements and implications of the Patient Protection and Affordable Care Act.
  Journal of the American Academy of Dermatology 2010 Resneck JS
• Shared medical appointments: will changes in health care delivery and financing promote increased use of nonphysician clinicians in dermatology patient counseling?
  Archives of dermatology 2010 Resneck JS, VanBeek M
• Individual drug sampling does not supplant the need for head-to-head trials in dermatology.
  Journal of the American Academy of Dermatology 2010 Resneck JS, Vanbeek M
• Patient safety: Part I. Patient safety and the dermatologist.
  Journal of the American Academy of Dermatology 2009 Elston DM, Taylor JS, Coldiron B, Hood AF, Read SI, Resneck JS, Kirsner RS, Maize JC, Sullivan S, Laskas J, Hanke CW
• Commentary: The relative ease of obtaining a dermatologic appointment in Boston: how methods drive results.
  Journal of the American Academy of Dermatology 2009 Feldman SR, Resneck JS
• A gender gap in the dermatology literature? Cross-sectional analysis of manuscript authorship trends in dermatology journals during 3 decades.
  Journal of the American Academy of Dermatology 2009 Feramisco JD, Leitenberger JJ, Redfern SI, Bian A, Xie XJ, Resneck JS
• Pediatric dermatology workforce shortage: perspectives from academia.
  Journal of the American Academy of Dermatology 2008 Craiglow BG, Resneck JS, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ
• The US dermatology workforce: a specialty remains in shortage.
  Journal of the American Academy of Dermatology 2008 Kimball AB, Resneck JS
• Who else is providing care in dermatology practices? Trends in the use of nonphysician clinicians.
  Journal of the American Academy of Dermatology 2008 Resneck JS, Kimball AB
• Short wait times for patients seeking cosmetic botulinum toxin appointments with dermatologists.
  Journal of the American Academy of Dermatology 2007 Resneck JS, Lipton S, Pletcher MJ
• Few Medicaid and uninsured patients are accessing dermatologists.
  Journal of the American Academy of Dermatology 2006 Resneck JS, Isenstein A, Kimball AB
• The influence of controllable lifestyle on medical student specialty choice.
  The virtual mentor : VM 2006 Resneck JS
• Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists.
  Journal of the American Academy of Dermatology 2006 Tsang MW, Resneck JS
• Dinners with Irwin: mentorship, the work force, and the future of academic dermatology.
  The Journal of investigative dermatology 2006 Resneck JS, Kimball AB
• Trends in malpractice premiums for dermatologists: results of a national survey.
  Archives of dermatology 2006 Resneck JS
• Challenges facing academic dermatology: survey data on the faculty workforce.
  Journal of the American Academy of Dermatology 2006 Resneck JS, Tierney EP, Kimball AB
• Etiology of pruritic papular eruption with HIV infection in Uganda.
  JAMA 2004 Resneck JS, Van Beek M, Furmanski L, Oyugi J, LeBoit PE, Katabira E, Kambugu F, Maurer T, Berger T, Pletcher MJ, Machtinger EL
• Generational differences in practice patterns of dermatologists in the United States: implications for workforce planning.
  Archives of dermatology 2004 Jacobson CC, Resneck JS, Kimball AB
• How health policy and health services researchers are compensated: analysis of a nationwide salary survey.
  Medical care research and review : MCRR 2004 Resneck J, Luft H
• Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times.
  Journal of the American Academy of Dermatology 2004 Resneck J, Pletcher MJ, Lozano N
• The dermatology workforce shortage.
  Journal of the American Academy of Dermatology 2004 Resneck J, Kimball AB
• Ducking stray "magic bullets": a Melan-A alert.
  The American Journal of dermatopathology 2003 Maize JC, Resneck JS, Shapiro PE, McCalmont TH, LeBoit PE
• Drug samples: friend or foe?
  Journal of drugs in dermatology : JDD 2002 Resneck J
• Too few or too many dermatologists? Difficulties in assessing optimal workforce size.
  Archives of dermatology 2001 Resneck J